Quantinno Capital Management LP Acquires 85,787 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Quantinno Capital Management LP raised its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 276.5% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 116,808 shares of the medical instruments supplier's stock after buying an additional 85,787 shares during the quarter. Quantinno Capital Management LP owned about 0.06% of DENTSPLY SIRONA worth $3,161,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Raymond James Trust N.A. increased its position in DENTSPLY SIRONA by 4.9% in the 2nd quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier's stock valued at $241,000 after acquiring an additional 453 shares during the period. State of Alaska Department of Revenue increased its position in DENTSPLY SIRONA by 2.4% in the 3rd quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier's stock valued at $637,000 after acquiring an additional 560 shares during the period. LRI Investments LLC increased its position in DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock valued at $31,000 after acquiring an additional 564 shares during the period. Diversified Trust Co increased its position in DENTSPLY SIRONA by 3.0% in the 2nd quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier's stock valued at $489,000 after acquiring an additional 566 shares during the period. Finally, Allworth Financial LP increased its position in DENTSPLY SIRONA by 40.2% in the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier's stock valued at $59,000 after acquiring an additional 625 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

Wall Street Analysts Forecast Growth

XRAY has been the topic of several research analyst reports. StockNews.com cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Tuesday, November 19th. Leerink Partners cut DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a research report on Thursday, November 7th. Robert W. Baird lowered their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating on the stock in a research report on Friday, November 8th. Needham & Company LLC lowered their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating on the stock in a research report on Friday, October 25th. Finally, Leerink Partnrs cut DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research report on Thursday, November 7th. Eight research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $28.40.

DENTSPLY SIRONA Price Performance

Shares of XRAY stock traded up $0.17 on Tuesday, reaching $19.62. 1,336,939 shares of the company's stock traded hands, compared to its average volume of 3,087,094. DENTSPLY SIRONA Inc. has a 12-month low of $17.21 and a 12-month high of $37.60. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The business's 50 day moving average price is $21.71 and its two-hundred day moving average price is $24.38.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company had revenue of $951.00 million during the quarter, compared to analysts' expectations of $939.10 million. During the same quarter in the previous year, the firm earned $0.49 earnings per share. The business's quarterly revenue was up .4% compared to the same quarter last year. Research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.